Plasma levels of nociceptin/orphanin FQ in patients with bipolar disorders and health adults

National Medical Journal of China

Volumn 89, Issue 13, 2009, Pages 916-918

  Wang, Li Ng ^a   Liu, Lan Fen ^b   Zhang, Jing Xuan ^b   Zhao, Gui Fang ^b  

^a SHANDONG UNIVERSITY   (China)

^b NONE

Author keywords

Bipolar disorder; Nociceptin

Indexed keywords

NOCICEPTIN;

ARTICLE; BECH-RAFAELSEN MANIA SCALE; BIPOLAR DEPRESSION; BIPOLAR MANIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HAMILTON SCALE; HUMAN; MALE; MENTAL HEALTH; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY;

ADOLESCENT; ADULT; BIPOLAR DISORDER; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OPIOID PEPTIDES; YOUNG ADULT;

EID: 77954901058     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2009.13.014     Document Type: Article

References (13)

1. Reinscheid RK, Nothacker HP, Bourson A, et al. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science, 1995, 270:792-794.
2. Witta J, Palkovits M, Rosenberger J, et al. Distribution of nociceptin/orphanin FQ in adult human brain. Brain Res, 2004, 997:24-29.
3. Berger B, Rothmaier AK, Franziska W, et al. Presynaptic opioid receptors on noradrenergic and serotonergic neurons in the human as compared to the rat neocortex. Br J Pharmacol, 2006, 148: 795-806.
4. Gyenge M, Hantos M. Laufer H, et al. Effect of nociceptin on histamine and serotonin release in the central nervous system. Acta Pharm Hung, 2006, 76:127-132.
5. Tao R, Ma Z, Thakkar MM, et al. Nociceptin/orphanin FQ decreases serotonin efflux in the rat brain but in contrast to a kappa-opioid has no antagonistic effect on mu- opioid-induced increases in serotonin efflux. Neuroscience, 2007, 147:106-116.
6. Marti M, Stocchi S, Paganini F, et al. Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex. Br J Phamracol. 2003, 138:91-98.
7. Liu Z, Wang Y, Zhang J , et al. Orphanin FQ: an endogenous antagonist of rat brain dopamine transporter. Neuroreport, 2001, 12:699-702.
8. Kotlinska J, Rafalski P, Biala C, et al. Nociceptin inhibits acquisition of amphetamine-induced place preference and sensitization to stereotypy in rats. Eur J Pharmacol, 2003, 474(2-3):233-239.
9. Zaveri N. Peptide and nonpeptide ligands for the nociceptin/orphanin FQ receptor ORL1: research tools and potential therapeutic agents. Life Sci, 2003, 73:663-678.
10. Gavioli EC, Marzola G, Guerrini R, et al. Blockade of nociceptin/orphanin FQ-NOP receptor signaling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test. Eur J Neurosci, 2003, 17: 1987-1990.
11. Gavioli EC, Vaughan CW, Marzola G, et al. Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice. Naunyu Schmiedebergs Arch Pharmacol, 2004, 369:547-553.